← All themes
Theme

3D Printing

Every analyzed stock in 3D Printing10 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
BURU
Nuburu, Inc.
Valuation N/A
Technology Risk 58 · Elevated
Price$1.35
Model IV
P/IV
Market implies +66.3%/yr vs model +15.0% · above model
DDD
3D SYSTEMS CORP
Valuation N/A
Technology Risk 32 · Moderate
Price$3.32
Model IV
P/IV
Market implies +34.2%/yr vs model +2.0% · above model
HPQ
HP INC
Deeply undervalued
Technology Risk 38 · Moderate
Price$35.48
Model IV$42.20
P/IV0.64
Discount 16% Return to IV: +18.9%
Market implies +3.4%/yr vs model +7.0% · below model
LASR
NLIGHT, INC.
Valuation N/A
Technology Risk 31 · Moderate
Price$40.37
Model IV
P/IV
Market implies +47.2%/yr vs model +2.0% · above model
MTLS
MATERIALISE NV
Valuation N/A
Technology Risk 41 · Elevated
Price$7.66
Model IV
P/IV
Limited data — see page
NNDM
Nano Dimension Ltd.
Valuation N/A
Technology Risk 33 · Moderate
Price$1.53
Model IV
P/IV
Market implies -50.0%/yr vs model +15.0% · below model
PRLB
Proto Labs Inc
Deeply overvalued
Industrials Risk 60 · High
Price$81.98
Model IV$19.78
P/IV3.83
Premium +314% Return to IV: -75.9%
Market implies +25.6%/yr vs model +6.6% · above model
SSYS
STRATASYS LTD.
Valuation N/A
Technology Risk 27 · Moderate
Price$7.72
Model IV
P/IV
Market implies +9.2%/yr vs model +2.0% · above model
VELO
Velo3D, Inc.
Valuation N/A
Industrials Risk 42 · Elevated
Price$10.53
Model IV
P/IV
Market implies +115.7%/yr vs model +13.8% · above model
XMTR
Xometry, Inc.
Deeply overvalued
Technology Risk 50 · Elevated
Price$86.11
Model IV$49.08
P/IV1.94
Premium +75% Return to IV: -43.0%
Market implies +12.7%/yr vs model +33.2% · below model